EdgarLookup

CNS Pharmaceuticals, Inc. — All Filings

368 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 1-A 1-A-W 1-A/A 10-K 10-K/A 10-Q 3 4 4/A 424B3 424B4 424B5 8-A12B 8-K 8-K/A ARS C C-AR C-TR C-U CERT CORRESP DEF 14A DEFA14A DEFR14A DOS DRS DRSLTR EFFECT FWP PRE 14A RW S-1 S-1/A S-3 S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001683168-25-002140 Mar 31, 2025
424B5 FORM 424B5 0001683168-25-001755 Mar 20, 2025
8-K FORM 8-K 0001683168-25-001754 Mar 20, 2025
8-K CURRENT REPORT 0001683168-25-001174 Feb 21, 2025 Feb 19, 2025
8-K CURRENT REPORT 0001683168-25-000077 Jan 3, 2025
8-K CURRENT REPORT 0001683168-24-008640 Dec 11, 2024
8-K FORM 8-K 0001683168-24-008464 Dec 3, 2024 Nov 26, 2024
DEFR14A DEFINITIVE REVISED PROXY SOLICITING MATERIALS 0001683168-24-008176 Nov 15, 2024
SC 13G/A 0001172661-24-005137 Nov 14, 2024
10-Q FORM 10-Q FOR SEPT 2024 0001683168-24-008125 Nov 14, 2024 Sep 30, 2024
8-K FORM 8-K 0001683168-24-007533 Nov 1, 2024 Oct 30, 2024
DEF 14A FORM DEF 14A 0001683168-24-007416 Oct 28, 2024 Nov 26, 2024
424B5 PROSPECTUS 0001683168-24-007336 Oct 24, 2024
8-K CURRENT REPORT 0001683168-24-007371 Oct 24, 2024 Oct 23, 2024
8-K CURRENT REPORT 0001683168-24-007304 Oct 23, 2024
PRE 14A FORM PRE 14A 0001683168-24-007160 Oct 15, 2024 Nov 26, 2024
8-K FORM 8-K 0001683168-24-006495 Sep 18, 2024 Sep 12, 2024
8-K CURRENT REPORT 0001683168-24-006318 Sep 12, 2024 Sep 10, 2024
10-Q FORM 10-Q FOR JUNE 2024 0001683168-24-005711 Aug 14, 2024 Jun 30, 2024
8-K CURRENT REPORT 0001683168-24-005311 Aug 7, 2024 Aug 6, 2024
3 3 0000950170-24-091952 Aug 6, 2024 Jul 29, 2024
4 4 0000950170-24-091993 Aug 6, 2024 Jul 30, 2024
SC 13D SC 13D 0001193125-24-192870 Aug 2, 2024
EFFECT 9999999995-24-002370 Aug 2, 2024
RW REQUEST FOR WITHDRAWAL 0001683168-24-005165 Jul 31, 2024
424B3 FORM 424B3 0001683168-24-005147 Jul 30, 2024
8-K CURRENT REPORT 0001683168-24-005145 Jul 30, 2024
8-K CURRENT REPORT 0001683168-24-005118 Jul 30, 2024 Jul 29, 2024
8-K CURRENT REPORT 0001683168-24-005070 Jul 26, 2024
424B5 PROSPECTUS 0001683168-24-005073 Jul 26, 2024
8-K CURRENT REPORT 0001683168-24-005023 Jul 24, 2024 Jul 19, 2024
S-1/A AMENDMENT NO. 1 0001683168-24-004962 Jul 19, 2024
8-K/A 8-K/A 0001683168-24-004772 Jul 12, 2024 Jul 5, 2024
S-1 FORM S-1 0001683168-24-004799 Jul 12, 2024
8-K CURRENT REPORT 0001683168-24-004708 Jul 9, 2024 Jul 5, 2024
424B5 FORM 424B5 0001683168-24-004688 Jul 5, 2024
8-K FORM 8-K 0001683168-24-004667 Jul 3, 2024
SC 13G 0001626947-24-000005 Jul 2, 2024
424B5 424B5 0001683168-24-004511 Jun 27, 2024
8-K CURRENT REPORT 0001683168-24-004501 Jun 26, 2024
SC 13G 0001626947-24-000004 Jun 25, 2024
8-K/A AMENDMENT TO CURRENT REPORT 0001683168-24-004367 Jun 20, 2024 Jun 14, 2024
424B5 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED MAY 17, 2024 0001683168-24-004259 Jun 17, 2024
8-K FORM 8-K 0001683168-24-004253 Jun 14, 2024
S-1 FORM S-1 0001683168-24-004062 Jun 10, 2024
8-K FORM 8-K 0001683168-24-003998 Jun 5, 2024 Jun 3, 2024
EFFECT 9999999995-24-001574 May 17, 2024
8-K FORM 8-K 0001683168-24-003550 May 16, 2024
10-Q FORM 10-Q FOR 3/31/24 0001683168-24-003531 May 15, 2024 Mar 31, 2024
CORRESP 0001683168-24-003530 May 15, 2024